Unity Biotechnology, Inc. (UBX)
UBX moved a median of 0.00% 30 minutes after news, and -1.63% by the close. How UBX actually reacts to news — the realized, point-in-time move the market made, measured across 105 labeled events over the last three years with zero look-ahead.
UBX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 30% | 104 |
| 30-min | 0.00% | 38% | 105 |
| 60-min | 0.00% | 38% | 105 |
| to close | -1.63% | 27% | 105 |
| Middle 50% of UBX reactions | -1.05% to +1.34% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 105 |
Half of all Unity Biotechnology, Inc. news events land between -1.05% and +1.34% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when UBX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to UBX's baseline. Nothing else.
Recent UBX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Unity Biotechnology, For: Jun 27 | SEC filing · Form 8-K | SEC EDGAR | -2.87% | -45.13% | |
| Form 8-K Unity Biotechnology, For: Jun 18 | SEC filing · Form 8-K | SEC EDGAR | -0.73% | -2.56% | |
| Form 8-K Unity Biotechnology, For: May 02 | SEC filing · Form 8-K | SEC EDGAR | +1.78% | -0.93% | |
| UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates | Press release | GlobeNewswire | +1.78% | -0.93% | |
| UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting | Press release | GlobeNewswire | -0.85% | -5.98% | |
| UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME | Press release | GlobeNewswire | -1.20% | -3.33% | |
| Form 10-Q Unity Biotechnology, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.20% | -3.33% | |
| Form 8-K Unity Biotechnology, For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | -1.20% | -3.33% | |
| UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates | Press release | GlobeNewswire | -1.20% | -3.33% | |
| Form 10-K/A Unity Biotechnology, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.01% | -1.59% | |
| Form 8-K Unity Biotechnology, For: Apr 03 | SEC filing · Form 8-K | SEC EDGAR | +0.80% | +5.97% | |
| Form 8-K Unity Biotechnology, For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | -8.70% | -5.80% | |
| UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema | Press release | GlobeNewswire | -8.70% | -5.80% | |
| UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 | Press release | GlobeNewswire | -8.70% | -5.80% | |
| Form 8-K Unity Biotechnology, For: Mar 14 | SEC filing · Form 8-K | SEC EDGAR | +1.71% | -1.14% | |
| Form 8-K Unity Biotechnology, For: Mar 08 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form 10-K Unity Biotechnology, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Unity Biotechnology, For: Mar 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form S-8 Unity Biotechnology, | SEC filing · Form S-8 | SEC EDGAR | +0.00% | +0.00% | |
| UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates | Press release | GlobeNewswire | +0.00% | +0.00% | |
| UNITY Biotechnology Reports Granting of New Employment Inducement Award | Press release | GlobeNewswire | -11.59% | -18.90% | |
| Form 8-K Unity Biotechnology, For: Jan 01 | SEC filing · Form 8-K | SEC EDGAR | +4.44% | +31.85% | |
| UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer | Press release | GlobeNewswire | +4.44% | +31.85% | |
| Form 10-Q Unity Biotechnology, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +3.10% | +5.22% | |
| Form 8-K Unity Biotechnology, For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | +3.10% | +5.22% | |
| UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates | Press release | GlobeNewswire | +3.10% | +5.22% | |
| UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 | Press release | GlobeNewswire | +0.00% | +0.70% | |
| UNITY Biotechnology to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form 10-Q Unity Biotechnology, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +1.44% | |
| Form 8-K Unity Biotechnology, For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.44% | |
| UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates | Press release | GlobeNewswire | +0.00% | +1.44% | |
| UNITY Biotechnology Reports Granting of New Employment Inducement Award | Press release | GlobeNewswire | +0.69% | +0.00% | |
| UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer | Press release | GlobeNewswire | +3.45% | +1.38% | |
| Form 8-K Unity Biotechnology, For: Jun 21 | SEC filing · Form 8-K | SEC EDGAR | -1.40% | -1.75% | |
| Form 10-Q Unity Biotechnology, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +5.14% | +0.66% | |
| Form 8-K Unity Biotechnology, For: May 14 | SEC filing · Form 8-K | SEC EDGAR | +5.14% | +0.66% | |
| UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates | Press release | GlobeNewswire | +5.14% | +0.66% | |
| Form ARS Unity Biotechnology, For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -1.32% | -0.66% | |
| Form DEF 14A Unity Biotechnology, For: Jun 21 | SEC filing · Form DEF | SEC EDGAR | -1.32% | -0.66% | |
| Form DEFA14A Unity Biotechnology, | SEC filing · Form DEFA14A | SEC EDGAR | -1.32% | -0.66% | |
| UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting | Press release | GlobeNewswire | +0.00% | +0.68% | |
| UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME | Press release | GlobeNewswire | -1.33% | -0.67% | |
| Form 10-K Unity Biotechnology, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -2.58% | -3.23% | |
| Form 8-K Unity Biotechnology, For: Apr 15 | SEC filing · Form 8-K | SEC EDGAR | -2.58% | -3.23% | |
| Form S-8 Unity Biotechnology, | SEC filing · Form S-8 | SEC EDGAR | -2.58% | -3.23% | |
| UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates | Press release | GlobeNewswire | -2.58% | -3.23% | |
| Form NT 10-K Unity Biotechnology, For: Dec 31 | SEC filing · Form NT | SEC EDGAR | -0.60% | -3.01% | |
| Form 8-K Unity Biotechnology, For: Mar 19 | SEC filing · Form 8-K | SEC EDGAR | -3.06% | -4.38% | |
| New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss | Press release | GlobeNewswire | +0.00% | +2.98% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the UBX section they belong to.
Where else UBX is measured.
UBX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IANTHUS CAPITAL HLDG ORD (ITHUF) | 105 | +2.50% | 60% |
| Supreme Cannabis Co Inc (SPRWF) | 105 | -0.13% | 41% |
| Creative Medical Technology Holdings, Inc. (CELZ) | 103 | 0.00% | 49% |
| COVALON TECHS LTD (CVALF) | 103 | 0.00% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Unity Biotechnology, Inc.'s median reaction calculated?
Every labeled UBX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 105 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of UBX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does UBX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.